Matt Roache | Director, IR |
Thomas McCourt | CEO & Director |
Michael Shetzline | Chief Medical Officer, SVP and Head, Research & Drug Development |
Sravan Emany | SVP, Principal Financial Officer & CFO |
David Amsellem | Piper Sandler & Co. |
Daniel Wolle | JPMorgan Chase & Co. |
Timothy Chiang | Capital One Securities |
Boris Peaker | Cowen and Company |
Good day, and welcome to the Ironwood Pharmaceuticals Q4 and Full Year 2022 Investor Update Conference Call. Today's call is being recorded. [Operator Instructions]. Thank you.
And I would now like to turn the conference over to Matt Roache, Director of Investor Relations.